Cellular Goods (CBX) Share Price, News & Analysis

Company Overview

Cellular Goods PLC, together with its subsidiaries, manufactures and sells biosynthetic cannabinoids-based consumer products in the United Kingdom. The company provides cannabinoid solutions for skincare and ingestible products. It offers its products through retailers; direct to consumers through its website; and online. The company was formerly known as Leaf Studios PLC and changed its name to Cellular Goods PLC in September 2020. The company was incorporated in 2018 and is based in London, United Kingdom.

Key Stats

• Today's Range: N/A
• 50-Day Range: 0.38 to 0.38
• 52-Week Range: N/A
• Volume: 999,059 shs
• Average Volume: 7.56 million shs
• Market Capitalization: £2.26 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CBX Stock Analysis - Frequently Asked Questions

How do I buy shares of Cellular Goods?

Shares of CBX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Cellular Goods own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cellular Goods investors own include Argo Blockchain (ARB), boohoo group (BOO), Diageo (DGE), Good Energy Group (GOOD), The Goldman Sachs Group (GS), Helium One Global (HE1) and International Consolidated Airlines Group (IAG).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Consumer Defensive
• Industry: Household & Personal Products
• Sub-Industry: N/A
• Current Symbol: LON:CBX
• CIK: N/A
• Web: www.cellulargoods.co
• Phone: N/A
• Fax: N/A
• Employees: 5
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): GBX (0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -£3.31 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -93.04%
• Return on Assets: -54.98%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 13.18
• Quick Ratio: 7.67

Sales & Book Value

• Annual Sales: £13.06 thousand
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 0.85
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 602,250,000
• Free Float: N/A
• Market Cap: £2.26 million
• Optionable: Not Optionable
• Beta: -1.39